Notable Upgrades: Amazon.com (AMZN), bluebird bio (BLUE), Sunesis (SNSS), RedHill (RDHL), Bio Blast Pharma (ORPN)

Amazon.com Inc. (AMZN) was reiterated a ‘Hold’ by Canaccord Genuity analysts on Monday. The broker also raised its price target on the stock to $400 from $380 saying it sees constructive signals in AWS growth, profitability, and potential valuation. Amazon’s AWS segment is expected to generate $15+ billion in revs by fiscal 2018 and expand […] View the full post at: Notable Upgrades: Amazon.com (AMZN), bluebird bio (BLUE), Sunesis (SNSS), RedHill (RDHL), Bio Blast Pharma (ORPN) Related posts: Amazon’s (AMZN) Cloud: A SaaS Solution Amazon’s Growth Warrants an Upgrade Amazon Acquires Zappos.com for $807 mln
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.